{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:27:29Z","timestamp":1794497249239,"version":"4.9.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"am","delay-in-days":269,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020167","name":"Gordon and Llura Gund Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR080659"],"award-info":[{"award-number":["R01 AR080659"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR072577"],"award-info":[{"award-number":["P30 AR072577"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR077607"],"award-info":[{"award-number":["R01 AR077607"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR070253"],"award-info":[{"award-number":["P30 AR070253"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00440930"],"award-info":[{"award-number":["RS-2024-00440930"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00279801"],"award-info":[{"award-number":["RS-2023-00279801"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL155522"],"award-info":[{"award-number":["R01 HL155522"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.semarthrit.2025.152729","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T12:57:38Z","timestamp":1744894658000},"page":"152729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-7194","authenticated-orcid":false,"given":"Sung Hae","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8361-0650","authenticated-orcid":false,"given":"Misti L.","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6107-9523","authenticated-orcid":false,"given":"You-Jung","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1981-742X","authenticated-orcid":false,"given":"Sung Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Woo","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Wan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yoon","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6975-8627","authenticated-orcid":false,"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-4618","authenticated-orcid":false,"given":"Jeffrey A.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semarthrit.2025.152729_bib0001","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.semarthrit.2016.10.007","article-title":"Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years","volume":"46","author":"Avouac","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152729_bib0002","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152729_bib0003","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152729_bib0004","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12931-021-01856-z","article-title":"Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"22","author":"Qiu","year":"2021","journal-title":"Respir Res"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152729_bib0005","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152729_bib0006","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/resp.13848","article-title":"Risk prediction model in rheumatoid arthritis-associated interstitial lung disease","volume":"25","author":"Kim","year":"2020","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152729_bib0007","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152729_bib0008","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152729_bib0009","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13075-024-03362-1","article-title":"Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study","volume":"26","author":"Song","year":"2024","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152729_bib0010","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1093\/rheumatology\/keac208","article-title":"The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease","volume":"61","author":"Brooks","year":"2022","journal-title":"Rheumatology"},{"issue":"18","key":"10.1016\/j.semarthrit.2025.152729_bib0011","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152729_bib0012","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10067-023-06623-7","article-title":"Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial","volume":"42","author":"Matteson","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152729_bib0013","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","article-title":"Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study","volume":"11","author":"Solomon","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152729_bib0014","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1093\/rheumatology\/kead027","article-title":"Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease","volume":"62","author":"Chang","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152729_bib0015","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s10067-024-07028-w","article-title":"Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease","volume":"43","author":"Venkat","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152729_bib0016","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152729_bib0017","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.2024-0713","article-title":"Serum biomarkers of pulmonary damage and risk for progression of rheumatoid arthritis-associated interstitial lung disease","author":"Chang","year":"2025","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152729_bib0018","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4078\/jrd.2021.28.4.234","article-title":"Association of serum biomarkers with pulmonary involvement of rheumatoid arthritis interstitial lung disease: from KORAIL cohort baseline data","volume":"28","author":"Moon","year":"2021","journal-title":"J Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152729_bib0019","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"25","key":"10.1016\/j.semarthrit.2025.152729_bib0020","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152729_bib0021","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrrheum.2014.115","article-title":"Lungs joints and immunity against citrullinated proteins in rheumatoid arthritis","volume":"10","author":"Catrina","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152729_bib0022","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","article-title":"Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease","volume":"79","author":"Castellanos-Moreira","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152729_bib0023","doi-asserted-by":"crossref","first-page":"00019","DOI":"10.1183\/23120541.00019-2016","article-title":"Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis","volume":"3","author":"Sokai","year":"2017","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152729_bib0024","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","article-title":"Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease","volume":"21","author":"Lee","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152729_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232978","article-title":"Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease","volume":"15","author":"Avouac","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152729_bib0026","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","article-title":"An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study","volume":"5","author":"Maher","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152729_bib0027","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S2213-2600(18)30185-1","article-title":"Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials","volume":"6","author":"Neighbors","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152729_bib0028","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41584-023-00969-7","article-title":"Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease","volume":"19","author":"Weber","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152729_bib0029","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152729_bib0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MCP.0000000000000908","article-title":"Epidemiology and real-life experience in progressive pulmonary fibrosis","volume":"28","author":"Valenzuela","year":"2022","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152729_bib0031","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02571-2021","article-title":"Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry","volume":"60","author":"Hambly","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2025.152729_bib0032","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-023-01212-z","article-title":"Clinical effect of progressive pulmonary fibrosis on patients with connective tissue disease-associated interstitial lung disease: a single center retrospective cohort study","author":"Lee","year":"2023","journal-title":"Clin Exp Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152729_bib0033","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02718-2020","article-title":"Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)","volume":"57","author":"Nasser","year":"2021","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152729_bib0034","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/1756-185X.14351","article-title":"Predictors of progression in rheumatoid arthritis-associated interstitial lung disease: a single-center retrospective study from China","volume":"25","author":"Liu","year":"2022","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152729_bib0035","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10067-018-4382-x","article-title":"Risk factors for progression and prognosis of rheumatoid arthritis\u2013associated interstitial lung disease: single center study with a large sample of Chinese population","volume":"38","author":"Fu","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"22","key":"10.1016\/j.semarthrit.2025.152729_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12227041","article-title":"Fibrosing progressive interstitial lung disease in rheumatoid arthritis: a multicentre Italian study","volume":"12","author":"Sebastiani","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2025.152729_bib0037","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rmed.2017.04.012","article-title":"The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease","volume":"127","author":"Morisset","year":"2017","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152729_bib0038","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.semarthrit.2019.04.005","article-title":"Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"49","author":"Singh","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152729_bib0039","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00085-2020","article-title":"The natural history of progressive fibrosing interstitial lung diseases","volume":"55","author":"Brown","year":"2020","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152729_bib0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr.22728","article-title":"Anti\u2013melanoma differentiation\u2013associated gene 5 is associated with rapidly progressive lung disease and poor survival in US patients with amyopathic and myopathic dermatomyositis","volume":"68","author":"Moghadam-Kia","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152729_bib0041","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1093\/rheumatology\/keaa786","article-title":"Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease","volume":"60","author":"Xu","year":"2020","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152729_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003121","article-title":"Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort","volume":"9","author":"Zanatta","year":"2023","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152729_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004240","article-title":"Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease","volume":"10","author":"Kuwana","year":"2024","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152729_bib0044","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/annrheumdis-2013-203947","article-title":"Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins","volume":"74","author":"Hensvold","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152729_bib0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-015-0520-x","article-title":"Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: implications for autoimmunity in rheumatoid arthritis","volume":"17","author":"Lugli","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152729_bib0046","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/annrheumdis-2012-202535","article-title":"Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease","volume":"73","author":"Fisher","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152729_bib0047","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/annrheumdis-2013-203915","article-title":"Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles","volume":"74","author":"Wagner","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152729_bib0048","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/annrheumdis-2015-208216","article-title":"Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis","volume":"75","author":"Reynisdottir","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152729_bib0049","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.42549","article-title":"Rheumatoid arthritis-specific autoimmunity in the lung before and at the onset of disease","volume":"75","author":"Joshua","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152729_bib0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","article-title":"Citrullination in extra-articular manifestations of rheumatoid arthritis","volume":"46","author":"Bongartz","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152729_bib0051","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02533-2020","article-title":"Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease","volume":"57","author":"Matson","year":"2021","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152729_bib0052","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2665-9913(22)00380-0","article-title":"Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: a nested case-control study","volume":"5","author":"Kronzer","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152729_bib0053","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/rheumatology\/keab828","article-title":"Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometry","volume":"61","author":"Alevizos","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2025.152729_bib0054","first-page":"9","article-title":"The burden of progressive-fibrosing interstitial lung diseases","author":"Cottin","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152729_bib0055","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01396-2021","article-title":"Lung function trajectory in progressive fibrosing interstitial lung disease","volume":"59","author":"Oldham","year":"2022","journal-title":"Eur Respir J"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:47:45Z","timestamp":1778629665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":55,"alternative-id":["S0049017225001003"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152729","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152729"}}